Tom Allen, Director at Syneos Health, Inc. (SYNH), sold 12,614,978 shares at $81.20 ($1.0B) on 2021-06-07, disclosed to the SEC on 2021-06-09.
Open-market sale of $1024.3M SYNH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.20 | 273,821 | $22.2M | 2.2% |
| 2 | $81.20 | 273,821 | $22.2M | 2.2% |
| 3 | $81.20 | 6,033,668 | $489.9M | 47.8% |
| 4 | $81.20 | 6,033,668 | $489.9M | 47.8% |
| Total | $81.20 avg | 12,614,978 | $1.0B | 100% |
| Filing → |
| SYNH | SELL | 2021-03-05 | $690.5M | — | Filing → |
| SYNH | SELL | 2020-12-07 | $395.7M | — | Filing → |
| SYNH | SELL | 2020-09-21 | $446.4M | — | Filing → |